+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Aseptic Pharma Processing Market, By Component, By Technology, By Product, By Application, By Region, Competition Forecast and Opportunities, 2017-2027

  • PDF Icon

    Report

  • 121 Pages
  • April 2022
  • Region: Global
  • TechSci Research
  • ID: 5575303
Free Webex Call
10% Free customization

The global aseptic pharma processing market is expected to grow at a significant rate during the forecast period

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global aseptic pharma processing market is expected to grow at a significant rate during the forecast period. The growth can be attributed to the rising demands for prolonged shelf-life of drugs, medicines, therapeutic creams, and other biological products. Aseptic pharma processing is performed to avoid degradation and ineffectiveness during terminal sterilizing. The technique guarantees the removal of bacteria and other microbial pathogens that can hamper the quality of the product. Increasing disposable income of people in developing countries and rising preference for eco-friendly packaging are anticipated to accelerate the growth of the global aseptic pharma processing market. Moreover, improved equipment and technologies in the packaging industry due to advances in technology are some of the factors driving the growth of the market. High capital requirement for specialized aseptic equipment and increasing instances of various chronic diseases, infectious diseases, and other illnesses are propelling the global aseptic pharma processing market growth. Increasing initiatives by the government to support the packaging industry with financial investments and other resources and growing usage of self-administered drugs are some of the factors expected to boost the growth of the global aseptic pharma processing market. Higher investment in the pharmaceutical industry for research and product development for the advanced pharmaceuticals are also propelling the growth of the global aseptic pharma processing market. Stringent measures by the Food & Drug Administration (FDA) have created a demand for high-quality pharma product packaging, which is expected to support the growth of global aseptic pharma processing market in the coming years.

The global aseptic pharma processing market is segmented on the basis of component, technology, product, application, regional distribution, and competitive Landscape. Based on the regional segmentation, North America is expected to hold the largest share in the global aseptic pharma processing market due to increased investment in research and development by biopharmaceutical companies based in the region. Besides, increased awareness about health among the US population has led to rising demand for generic and OTC drugs, boosting the aseptic pharma processing market growth in the region.

Top companies dominating the global aseptic pharma processing market are Abbvie Inc., Lonza Group, Baxter International Inc., Recipharm AB, August Bioservices, LLC, Vetter Pharma-Fertigung GmbH & Co. KG, Berkshire Sterile Manufacturing, Recro Pharma Inc., Samsung Biologics, Symbiosis Pharmaceutical Services Ltd., Catalent Pharma Solutions Inc., Alcami Corporation, LSNE Contract Manufacturing, IRISYS, Robert Bosch GmbH, etc.

Years Considered for This Report:

  • Historical Years: 2017-2020
  • Base Year: 2021
  • Estimated Year: 2022E
  • Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global aseptic pharma processing market from 2017 to 2021
  • To estimate and forecast the market size of global aseptic pharma processing market from 2022E to 2027F and growth rate until 2027F
  • To classify and forecast global aseptic pharma processing market based on component, processing equipment, packaging equipment, technology, product, application, region, and competitive Landscape
  • To identify dominant region or segment in the global aseptic pharma processing market
  • To identify drivers and challenges for global aseptic pharma processing market
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc, in global aseptic pharma processing market
  • To identify and analyze the profile of leading players operating in global aseptic pharma processing market
  • To identify key sustainable strategies adopted by market players in global aseptic pharma processing market

Report Scope:


In this report, global aseptic pharma processing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Aseptic Pharma Processing Market, By Component:

  • Processing Equipment
  • Drying Equipment
  • Extruders
  • Granulation Equipment
  • Tablet Compression
  • Fill/Finish Equipment
  • Mixing Equipment
  • Others
  • Packaging Equipment
  • Inspection Machines
  • Labeling Machines
  • Aseptic Packaging Machines

Aseptic Pharma Processing Market, By Technology:

  • Drying
  • Lyophilization
  • Closed Vial Technology
  • Blow Fill Seal Technology
  • Others

Aseptic Pharma Processing Market, By Product:

  • Corticosteroids
  • Antibiotics
  • Antagonists
  • Biologics
  • Others

Aseptic Pharma Processing Market, By Application:

  • Ophthalmic Suspensions
  • Reconstituted Lyophilized Powders for Injection
  • Sterile Injectables
  • Aqueous-Based Aerosols for Inhalation
  • Others

Aseptic Pharma Processing Market, By Region:


North America

  • United States
  • Mexico
  • Canada
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies, which could not be identified due to the limitations of secondary research. The publisher analyzed the companies, distribution channels and presence of all major players across the globe.

The publisher calculated the market size of global aseptic pharma processing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

  • Aseptic pharma processing companies/partners
  • Suppliers/Distributers
  • End-Users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to global aseptic pharma processing market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in global aseptic pharma processing market

Available Customizations:


With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:
  • Company Information
  • Detailed analysis and profiling of additional market players (up to five)


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Aseptic Pharma Processing Market
4. Voice of Customer
4.1. Factors Contributing to Demand for Aseptic Pharma Processing
4.2. Preference, By Component
4.3. Preference, By Processing Equipment
4.4. Preference, By Packaging Equipment
4.5. Commonly Used Technology in Aseptic Pharma Processing
4.6. Demand for Aseptic Pharma Processing, By Product
4.7. Brand Awareness
5. Executive Summary
6. Global Aseptic Pharma Processing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component (Processing Equipment v/s Packaging Equipment)
6.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others)
6.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines)
6.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others)
6.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others)
6.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Aseptic Pharma Processing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component (Processing Equipment v/s Packaging Equipment)
7.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others)
7.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines)
7.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others)
7.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others)
7.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others)
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Aseptic Pharma Processing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Technology
7.3.1.2.3. By Product
7.3.1.2.4. By Application
7.3.2. Mexico Aseptic Pharma Processing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Technology
7.3.2.2.3. By Product
7.3.2.2.4. By Application
7.3.3. Canada Aseptic Pharma Processing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Technology
7.3.3.2.3. By Product
7.3.3.2.4. By Application
8. Europe Aseptic Pharma Processing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component (Processing Equipment v/s Packaging Equipment)
8.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others)
8.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines)
8.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others)
8.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others)
8.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others)
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Aseptic Pharma Processing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Technology
8.3.1.2.3. By Product
8.3.1.2.4. By Application
8.3.2. Germany Aseptic Pharma Processing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Technology
8.3.2.2.3. By Product
8.3.2.2.4. By Application
8.3.3. United Kingdom Aseptic Pharma Processing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Technology
8.3.3.2.3. By Product
8.3.3.2.4. By Application
8.3.4. Italy Aseptic Pharma Processing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Technology
8.3.4.2.3. By Product
8.3.4.2.4. By Application
8.3.5. Spain Aseptic Pharma Processing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Technology
8.3.5.2.3. By Product
8.3.5.2.4. By Application
9. Asia-Pacific Aseptic Pharma Processing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component (Processing Equipment v/s Packaging Equipment)
9.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others)
9.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines)
9.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others)
9.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others)
9.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others)
9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Aseptic Pharma Processing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Technology
9.3.1.2.3. By Product
9.3.1.2.4. By Application
9.3.2. India Aseptic Pharma Processing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Technology
9.3.2.2.3. By Product
9.3.2.2.4. By Application
9.3.3. Japan Aseptic Pharma Processing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Technology
9.3.3.2.3. By Product
9.3.3.2.4. By Application
9.3.4. South Korea Aseptic Pharma Processing Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Component
9.3.4.2.2. By Technology
9.3.4.2.3. By Product
9.3.4.2.4. By Application
9.3.5. Australia Aseptic Pharma Processing Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Component
9.3.5.2.2. By Technology
9.3.5.2.3. By Product
9.3.5.2.4. By Application
10. South America Aseptic Pharma Processing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component (Processing Equipment v/s Packaging Equipment)
10.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others)
10.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines)
10.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others)
10.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others)
10.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others)
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Aseptic Pharma Processing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Technology
10.3.1.2.3. By Product
10.3.1.2.4. By Application
10.3.2. Argentina Aseptic Pharma Processing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Technology
10.3.2.2.3. By Product
10.3.2.2.4. By Application
10.3.3. Colombia Aseptic Pharma Processing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Technology
10.3.3.2.3. By Product
10.3.3.2.4. By Application
11. Middle East and Africa Aseptic Pharma Processing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Component (Processing Equipment v/s Packaging Equipment)
11.2.1.1. By Processing Equipment (Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others)
11.2.1.2. By Packaging Equipment (Inspection Machines, Labeling Machines, Aseptic Packaging Machines)
11.2.2. By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others)
11.2.3. By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others)
11.2.4. By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others)
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Aseptic Pharma Processing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Component
11.3.1.2.2. By Technology
11.3.1.2.3. By Product
11.3.1.2.4. By Application
11.3.2. Saudi Arabia Aseptic Pharma Processing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Component
11.3.2.2.2. By Technology
11.3.2.2.3. By Product
11.3.2.2.4. By Application
11.3.3. UAE Aseptic Pharma Processing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Component
11.3.3.2.2. By Technology
11.3.3.2.3. By Product
11.3.3.2.4. By Application
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments14. Patent Analysis
15. Competitive Landscape
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (In case of listed companies)
15.5. Recent Developments
15.6. SWOT Analysis
15.6.1. Abbvie Inc.
15.6.2. Lonza Group
15.6.3. Baxter International Inc.
15.6.4. Recipharm AB
15.6.5. August Bioservices, LLC
15.6.6. Vetter Pharma-Fertigung GmbH & Co. KG
15.6.7. Berkshire Sterile Manufacturing
15.6.8. Recro Pharma Inc.
15.6.9. Samsung Biologics
15.6.10. Symbiosis Pharmaceutical Services Ltd.
15.6.11. Catalent Pharma Solutions Inc.
15.6.12. Alcami Corporation
15.6.13. LSNE Contract Manufacturing
15.6.14. IRISYS
15.6.15. Robert Bosch GmbH
16. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbvie Inc.
  • Lonza Group
  • Baxter International Inc.
  • Recipharm AB
  • August Bioservices, LLC
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Berkshire Sterile Manufacturing
  • Recro Pharma Inc.
  • Samsung Biologics
  • Symbiosis Pharmaceutical Services Ltd.
  • Catalent Pharma Solutions Inc.
  • Alcami Corporation
  • LSNE Contract Manufacturing
  • IRISYS
  • Robert Bosch GmbH